JEAN-LOUIS CONSTANZA

WANDERCRAFT

Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.

dont miss

Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations

The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.

EVEN MORE SEMINARS

  • JEAN-LOUIS CONSTANZA: Speaking at the European Neurological Convention

    JEAN-LOUIS CONSTANZA
    WANDERCRAFT

    Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations

  • Professor Gus A Baker: Speaking at the European Neurological Convention

    Professor Gus A Baker
    Tribune Neuropsychology Services, University of Liverpool, Walton Centre for Neurology& Neurosurgery

    The additional burden of epilepsy: a psychological and neuropsychological perspective

  • Dr Srinivas Lanka: Speaking at the European Neurological Convention

    Dr Srinivas Lanka
    Cygnet Health Care

    Measuring Outcomes in Neuropsychiatry

  • Eva Sobonova <br>  Sarah Harris <br > Mary Brady: Speaking at the European Neurological Convention

    Eva Sobonova
    Sarah Harris
    Mary Brady

    The Buckinghamshire Group

    TBA

  • Dr Martine Stoffels: Speaking at the European Neurological Convention

    Dr Martine Stoffels
    Priory Brain Injury Services & Phoenix Mental Health Services

    r-TMS in neuropsychiatric conditions.